|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Norwegian University of Science and Technology |
|---|---|
| Information provided by: | Norwegian University of Science and Technology |
| ClinicalTrials.gov Identifier: | NCT00397774 |
Purpose
The project consists of two studies where we want to throw light on the importance of physical activity/exercise to maintain physical function among cancer patients whose disease is not responsive to curative treatment. Study I is a randomised intervention study where we want to study the effect of adjusted physical exercise compared to usual care. In study II our main aim is to validate different subjective and objective methods to measure physical functioning
| Condition | Intervention | Phase |
|---|---|---|
|
Palliative Care Cancer Physical Exercise Physical Function |
Behavioral: Physical exercise Behavioral: physiacl exercise vs treatment as usual |
Phase III |
| Study Type: | Interventional |
| Study Design: | Supportive Care, Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study |
| Official Title: | Phase 3 Physical Activity and Functioning in Palliative Cancer Patients - a Clinical Randomised Trial |
| Estimated Enrollment: | 160 |
| Study Start Date: | October 2006 |
| Estimated Study Completion Date: | June 2009 |
| Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
1: Active Comparator
Physical exercise twice a week for 8 weeks
|
Behavioral: Physical exercise
Physical exercise twice a week for 8 weeks
|
|
2: No Intervention
Treatment as usual
|
Behavioral: physiacl exercise vs treatment as usual
treatment as usual
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contacts and Locations| Norway | |
| Institute for cancer and molecular research | Recruiting |
| Trondheim, Norway, 7006 | |
| Contact: Line M Oldervoll, PhD +4773867264 line.oldervoll@ntnu.no | |
| Principal Investigator: Line M Oldervoll, PhD | |
| Principal Investigator: | Line M Oldervoll, PhD | Department of Cancer Reserach and Molecular Medicine |
More Information
| Responsible Party: | Institute for cancer research and molecular medicine, NTNU ( Line Oldervoll ) |
| Study ID Numbers: | 4.2006.2179 |
| Study First Received: | November 9, 2006 |
| Last Updated: | May 20, 2008 |
| ClinicalTrials.gov Identifier: | NCT00397774 |
| Health Authority: | Norway: Norwegian Social Science Data Services |
